Aardvark Therapeutics, Inc.（AARD）價格預測AARDAardvark Therapeutics, Inc.

Alphio's AARD stock price prediction model matches the current Aardvark Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.77 (-0.17%). The 1-week path is $3.50 (-7.32%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Aardvark Therapeutics is not a good buy right now due to significant financial losses and regulatory issues. The current price is $3.78, and the company has reported a net loss of $14.4 million in Q2 2026. Additionally, the RSI is extremely low at 12.423, indicating oversold conditions, but this is a sign of weakness rather than a buying opportunity. The main risk is the FDA clinical hold on their lead drug ARD-101, which has led to a 30% drop in stock price and ongoing uncertainty in their research and development efforts.

Aardvark Therapeutics, Inc. (AARD) last closed at $3.78, losing -2.07%. These facts feed the 1-day and 1-week AARD price prediction above.